Literature DB >> 30605242

Metabolically Healthy Obesity and Risk for Atrial Fibrillation: The HUNT Study.

Tingting Feng1, Malmo Vegard2,3, Linn B Strand1, Lars E Laugsand2,3, Bjørn Mørkedal4, Dagfinn Aune5,6,7, Lars Vatten1, Hanne Ellekjaer8,9, Jan P Loennechen2,3, Kenneth Mukamal10, Imre Janszky1,11,12.   

Abstract

OBJECTIVE: Atrial fibrillation (AF) is the most common arrhythmia and has been described as a global epidemic. Although AF is associated with both obesity and its metabolic consequences, little is known about the association between metabolically healthy obesity and AF.
METHODS: In a population-based study, 47,870 adults were followed for incident AF from 2006 to 2008 until 2015. Participants were classified according to BMI and metabolic status (using waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, and glucose) at baseline.
RESULTS: During a median follow-up of 8.1 years, 1,758 participants developed AF. Compared with metabolically healthy individuals with BMI < 25 kg/m2 , the multivariable-adjusted hazard ratios for metabolically healthy and unhealthy obesity were 1.6 (95% CI: 1.2 to 2.1) and 1.6 (95% CI: 1.3 to 1.9), respectively. AF risk increased according to the severity of obesity.
CONCLUSIONS: Metabolically healthy and unhealthy obesity increased AF risk to a similar extent. Severity of obesity was positively associated with AF risk regardless of metabolic status.
© 2019 The Obesity Society.

Entities:  

Mesh:

Year:  2019        PMID: 30605242     DOI: 10.1002/oby.22377

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  9 in total

Review 1.  Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.

Authors:  Benedict J Maliakkal
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

2.  Transition of Metabolic Phenotypes and Risk of Atrial Fibrillation According to BMI: Kailuan Study.

Authors:  Maoxiang Zhao; Wenjuan Du; Qianqian Zhao; Yating Chen; Bin Li; Zhonghui Xie; Zihao Fu; Nan Zhang; Xiaowei Cheng; Xiaoqian Li; Siyu Yao; Miao Wang; Chi Wang; Shouling Wu; Hao Xue; Yang Li
Journal:  Front Cardiovasc Med       Date:  2022-06-28

3.  Long-term metabolic fate and mortality in obesity without metabolic syndrome.

Authors:  Aki Juhani Käräjämäki; Arto Korkiakoski; Janne Hukkanen; Y Antero Kesäniemi; Olavi Ukkola
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

4.  All-cause mortality in metabolically healthy individuals was not predicted by overweight and obesity.

Authors:  Qiuyue Tian; Anxin Wang; Yingting Zuo; Shuohua Chen; Haifeng Hou; Wei Wang; Shouling Wu; Youxin Wang
Journal:  JCI Insight       Date:  2020-08-20

5.  Obesity phenotypes and their relationships with atrial fibrillation.

Authors:  Szu-Ying Tsai; Hsin-Hao Chen; Hsin-Yin Hsu; Ming-Chieh Tsai; Le-Yin Hsu; Lee-Ching Hwang; Kuo-Liong Chien; Chien-Ju Lin; Tzu-Lin Yeh
Journal:  PeerJ       Date:  2021-10-28       Impact factor: 2.984

6.  Association between metabolically healthy obesity and risk of atrial fibrillation: taking physical activity into consideration.

Authors:  Ruoting Wang; Ivan Olier; Sandra Ortega-Martorell; Yingxin Liu; Zebing Ye; Gregory Yh Lip; Guowei Li
Journal:  Cardiovasc Diabetol       Date:  2022-10-13       Impact factor: 8.949

7.  Joint Associations of Obesity and NT-proBNP With the Incidence of Atrial Fibrillation in the ARIC Study.

Authors:  Zakaria Almuwaqqat; Wesley T O'Neal; Faye L Norby; Pamela L Lutsey; Elizabeth Selvin; Elsayed Z Soliman; Lin Y Chen; Alvaro Alonso
Journal:  J Am Heart Assoc       Date:  2019-09-28       Impact factor: 5.501

8.  Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial.

Authors:  Nele Gessler; Stephan Willems; Daniel Steven; Jens Aberle; Ruken Oezge Akbulak; Nils Gosau; Boris A Hoffmann; Christian Meyer; Arian Sultan; Roland Tilz; Julia Vogler; Peter Wohlmuth; Susanne Scholz; Melanie A Gunawardene; Christian Eickholt; Jakob Lüker
Journal:  Europace       Date:  2021-10-09       Impact factor: 5.214

9.  Effect of body shape on the development of cardiovascular disease in individuals with metabolically healthy obesity.

Authors:  Chang-Myung Oh; Jung Hwan Park; Hye Soo Chung; Jae Myung Yu; Wankyo Chung; Jun Goo Kang; Shinje Moon
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.